A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Recruiting

Phase 2 Results N/A

Main Contacts

Name Phone E-mail
Clinical Trials Study Director
Reference Study ID Number: BP29937 www.roche.com/about_roche/roche_worldwide.htm Contact 888-662-6728 (U.S. and Canada) global.rochegenentechtrials@roche.com